JPRN-UMIN000006836招募中2 期
Role of Diabetes in heart failure with preserved left ventricular function - HFPEF and DM
Department of Cardiology, Nagoya University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Major cardiovascular events within 3 months after registration Left ventricular ejection fraction is less than 50 percent Left ventricular diastolic diameter is more than 49mm Comorbid atrial fibrillation Diabetic patients who is treated by DPP-4 inhibitors and/or GLP-1analog Patients with CKD [eGFR less than 30ml] and ESRD Type 1 diabetes Malignancy within 5 years at registration Uncontrolled cormobid arrhythmia Uncontrolled cormobid hypertension Hospitalization within 6 month Diabetic patients who is treated by insulin Comorbid severe valuvular heart disease Comorbid severe ischemic heart disease Liver injury [ALT/AST values exhibit 5 times higher than normal range] Pregnancy
研究者
相似试验
已完成
不适用
Mechanisms and Reversibility of Heart Failure Associated With DiabetesType 2 DiabetesNCT01970319Dr. Peter Swoboda110
尚未招募
不适用
Investigation of the effects of heart failure with preserved ejection fraction (HFpEF) on cerebral small vessel diseaseHeart failure with preserved ejection fraction (HFpEF)DRKS00031583niversitätsklinikum Magdeburg102
招募中
不适用
Mitochondrial Substrate Utilization in the Diabetic Human HeartHeart FailureType2diabetesMitochondrial DiseasesDiabetic CardiomyopathiesInsulin ResistanceNCT05958706Heinrich-Heine University, Duesseldorf500
进行中（未招募）
不适用
Effects on subclinical heartfailure in type 2 diabetic subjects on liraglutide treatment versus glimepiride both in combination with metformin. - Liraglutide and heartfailureEUCTR2010-022695-31-SEKarolinska Institute, Södersjukhuset AB
进行中（未招募）
4 期
ASCEND PLUS - a research study to test whether a treatment called oral semaglutide can protect people with type 2 diabetes from heart attacks, strokes, and other health problemsISRCTN76193287niversity of Oxford20,000